Kent A Robertson
Affiliation: Indiana University
- Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson
Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Lancet Oncol 13:1218-24. 2012..We undertook an open-label phase 2 trial to test whether treatment with imatinib mesylate can decrease the volume burden of clinically significant plexiform neurofibromas in patients with NF1...
- Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromasBoaz Karmazyn
Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Riley Hospital for Children, Indiana University Health, 705 Riley Hospital Drive, Rm 1053, Indianapolis, IN 46260, USA
Pediatr Radiol 42:1218-22. 2012..We observed bone marrow signal changes (BMSC) in patients with plexiform neurofibromas after treatment with imatinib mesylate (Gleevec)...
- Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosisMelissa L Fishel
Department of Pediatrics Section of Hematology Oncology, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 980 W Walnut, Indianapolis, IN 46202, USA
Exp Hematol 38:1178-88. 2010....
- CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiationNandini Dey
Section of Pediatric Hematology Oncology, Department of Pediatrics, AFLAC Cancer Center and Blood Disorders Services, Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30022, USA
Mol Cell Biol 27:4179-97. 2007..We have elucidated a nongenomic extranuclear signal mediated by the RAR-SRC interaction that is negatively regulated by CSK and is required for RA-induced neuronal differentiation...
- Serial transplantation resulting in tolerance to an unrelated cord blood graftW Scott Goebel
Department of Pediatrics and the Pediatric Stem Cell Transplantation Program, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN 46202 5200, USA
Transplantation 81:1596-9. 2006....
- Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency diseaseSrilatha Atluri
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
J Pediatr Hematol Oncol 29:166-72. 2007..The clinical course of Epstein-Barr virus (EBV)-associated smooth muscle tumors is variable and there are no reports in patients with mixed T-cell chimerism after bone marrow transplantation (BMT)...
- Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemiaFranklin O Smith
Division of Hematology Oncology, Children s Hospital Medical Center, Cincinnati, OH 45229, USA
Br J Haematol 116:716-24. 2002..With lower relapse observed in patients with chronic GVHD, new treatment strategies that focus on enhancing the graft-versus-leukaemia effect may improve survival...
- APE EXPRESSION/LEUKEMIA RESPONSE TO CHEMO/RADIOTHERAPYKent Robertson; Fiscal Year: 2001....